Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026
Zhengye Biotechnology announced unaudited financial results for the six months ended June 30, 2026. Its co-CEO said the company continued to enhance profitability through disciplined cost management and operational efficiency.
Why it matters — The announcement provides ZYBT watchers with a midyear update on the company’s financial results and management’s comments on profitability efforts.